Relationship between M6A methylation regulator and prognosis in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization

BACKGROUND: Patients with mid-stage HCC (hepatocellular carcinoma) may benefit from transcatheter arterial chemoembolization (TACE). However, patient efficacy varies widely, and the detailed assessment index is unknown. The most general methylation alteration in mRNA (Messenger RNA), N6-methyladenos...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Deliang, Huang, Dejing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573888/
https://www.ncbi.nlm.nih.gov/pubmed/36262291
http://dx.doi.org/10.1016/j.heliyon.2022.e10931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573888/
https://www.ncbi.nlm.nih.gov/pubmed/36262291
http://dx.doi.org/10.1016/j.heliyon.2022.e10931

Ejemplares similares